×
ADVERTISEMENT

SEPTEMBER 22, 2021

Ig FAQ: What’s the Future for Ig Therapies?

A Review of Data on Potential Products

Jerry Siegel, PharmD, FASHP
Clinical Associate Professor
The Ohio State University College of Pharmacy
Columbus, Ohio 
VP Business Development
Managing Partner, Safe Medication Management
East Greenwich, Rhode Island

 

Currently, 14 different immunoglobulin (Ig) products are on the market, with 6 FDA-approved indications: primary immunodeficiency (PID), idiopathic thrombocytopenic purpura (ITP), chronic lymphocytic leukemia, multifocal motor neuropathy, chronic inflammatory demyelinating